Next Article in Journal / Special Issue
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
Previous Article in Journal
Treatment Strategies and Survival Outcomes in Breast Cancer
Previous Article in Special Issue
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
 
 
Article

Article Versions Notes

Cancers 2020, 12(3), 737; https://doi.org/10.3390/cancers12030737
Action Date Notes Link
article html file updated 24 December 2025 18:03 CET Update https://www.mdpi.com/2072-6694/12/3/737/html
article html file updated 31 August 2025 15:00 CEST Update -
article html file updated 20 July 2022 23:30 CEST Update -
article html file updated 2 April 2020 06:36 CEST Update -
article html file updated 23 March 2020 16:21 CET Original file -
article pdf uploaded. 23 March 2020 16:19 CET Updated version of record https://www.mdpi.com/2072-6694/12/3/737/pdf
article xml uploaded. 23 March 2020 16:19 CET Update https://www.mdpi.com/2072-6694/12/3/737/xml
article xml file uploaded 23 March 2020 16:19 CET Update -
article supplementary file uploaded. 20 March 2020 13:12 CET - https://www.mdpi.com/2072-6694/12/3/737#supplementary
article pdf uploaded. 20 March 2020 13:12 CET Version of Record https://www.mdpi.com/2072-6694/12/3/737/pdf-vor
article xml file uploaded 20 March 2020 13:12 CET Original file -
Back to TopTop